Benperidol

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Benperidol
Accession Number
DB12867
Description

Benperidol has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders, among others.

Type
Small Molecule
Groups
Approved, Investigational
Structure
Thumb
Weight
Average: 381.451
Monoisotopic: 381.185255188
Chemical Formula
C22H24FN3O2
Synonyms
  • Benperidol
  • Benperidolum
External IDs
  • CB 8089
  • MCN-JR-4584
  • R 4584
  • R-4584

Pharmacology

Indication
Not Available
Associated Conditions
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetazolamideThe risk or severity of adverse effects can be increased when Acetazolamide is combined with Benperidol.
AcetophenazineThe risk or severity of adverse effects can be increased when Acetophenazine is combined with Benperidol.
AclidiniumBenperidol may increase the central nervous system depressant (CNS depressant) activities of Aclidinium.
AgomelatineThe risk or severity of adverse effects can be increased when Agomelatine is combined with Benperidol.
AlfentanilThe risk or severity of adverse effects can be increased when Alfentanil is combined with Benperidol.
AlimemazineThe risk or severity of adverse effects can be increased when Alimemazine is combined with Benperidol.
AlmotriptanThe risk or severity of adverse effects can be increased when Almotriptan is combined with Benperidol.
AlosetronThe risk or severity of adverse effects can be increased when Alosetron is combined with Benperidol.
AlprazolamThe risk or severity of adverse effects can be increased when Alprazolam is combined with Benperidol.
AlverineThe risk or severity of adverse effects can be increased when Alverine is combined with Benperidol.
Additional Data Available
  • Extended Description
    Extended Description
    Available for Purchase

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity
    Available for Purchase

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level
    Available for Purchase

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action
    Available for Purchase

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

Products

Purchasing individual compounds or compound libraries for your research?
Learn More
International/Other Brands
Anquil / Benquil

Categories

ATC Codes
N05AD07 — Benperidol
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as alkyl-phenylketones. These are aromatic compounds containing a ketone substituted by one alkyl group, and a phenyl group.
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organooxygen compounds
Sub Class
Carbonyl compounds
Direct Parent
Alkyl-phenylketones
Alternative Parents
Phenylbutylamines / Butyrophenones / Benzimidazoles / Aryl alkyl ketones / Benzoyl derivatives / Fluorobenzenes / Piperidines / Aryl fluorides / N-substituted imidazoles / Gamma-amino ketones
show 8 more
Substituents
Alkyl-phenylketone / Amine / Aromatic heteropolycyclic compound / Aryl alkyl ketone / Aryl fluoride / Aryl halide / Azacycle / Azole / Benzenoid / Benzimidazole
show 22 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
Not Available

Chemical Identifiers

UNII
97O6X78C53
CAS number
2062-84-2
InChI Key
FEBOTPHFXYHVPL-UHFFFAOYSA-N
InChI
InChI=1S/C22H24FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-10,18H,3,6,11-15H2,(H,24,28)
IUPAC Name
1-(4-fluorophenyl)-4-[4-(2-hydroxy-1H-1,3-benzodiazol-1-yl)piperidin-1-yl]butan-1-one
SMILES
OC1=NC2=CC=CC=C2N1C1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1

References

General References
  1. AIFA Product Information: Benperidol-neuraxpharm (benperidol) solution for injection [Link]
  2. AIFA Product Information: Glianimon (benperidol) for oral use [Link]
PubChem Compound
16363
PubChem Substance
347829025
ChemSpider
15521
BindingDB
81492
RxNav
1373
ChEBI
93403
ChEMBL
CHEMBL297302
ZINC
ZINC000009232411
Wikipedia
Benperidol

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedTreatmentSchizoaffective Disorders / Schizophrenia / Schizophrenia and Disorders With Psychotic Features1
3TerminatedTreatmentAnxiety Disorders / Dementia / Depression / Psychosomatic Disorders / Schizophrenia1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntramuscular; Intravenous2 mg/100mL
Injection, solutionIntramuscular; Intravenous2 mg/30mL
Tablet10 MG
Tablet2 MG
Tablet4 MG
Tablet
SolutionOral1 mg/mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0306 mg/mLALOGPS
logP3.6ALOGPS
logP3.79ChemAxon
logS-4.1ALOGPS
pKa (Strongest Acidic)11.67ChemAxon
pKa (Strongest Basic)8.55ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area58.36 Å2ChemAxon
Rotatable Bond Count6ChemAxon
Refractivity106.34 m3·mol-1ChemAxon
Polarizability41.85 Å3ChemAxon
Number of Rings4ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
MS/MS Spectrum - , positiveLC-MS/MSsplash10-01b9-3911000000-e206a343ec091deafac6

Drug created on October 20, 2016 18:52 / Updated on October 24, 2020 01:30

Pm 5